Bacterial Disease Diagnostics Market Analysis

  • Report ID: 5206
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Bacterial Disease Diagnostics Segmentation

Type (Bacterial Skin Infections, Sexually Transmitted Infections, Foodborne Infections)

The bacterial skin infections segment in the bacterial disease diagnostics market is estimated to gain the largest revenue share of about 45% in the year 2037. The growth of the segment can be attributed to the rising skin problem among the people. Skin is the most exposed part of the body, therefore many people get affected by acne, infection, and allergies caused by bacterial growth. Acne is the 8th most common disease in the world and affects around 9% of the total global population.

End User (Hospitals, Labs, Research Centers)

Bacterial disease diagnostics market from hospital segment is expected to garner a significant share of around 40% in the year 2037. Hospitals play a significant part in patient care, and good diagnostic procedures are key for guiding treatment plans, improving patient outcomes, and limiting infection spread. Furthermore, the governments of various countries are increasing the budget for setting up hospital infrastructures, which is expected to drive the growth of the segment.

Our in-depth analysis of the global market includes the following segments:

          Type

  • Bacterial Skin Infections
  • Sexually Transmitted Infections
  • Foodborne Infections

          Product

  • Consumables
  • Instruments

          Technology

  • Isothermal Nucleic Acid Amplification Technology
  • Polymerase Chain Reaction
  • DNA Microarray
  • Immunodiagnostics

          End User

  • Hospitals
  • Labs
  • Research Centers

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of bacterial disease diagnostics is assessed at USD 3.95 billion.

The bacterial disease diagnostics market size was valued at USD 3.49 billion in 2024 and is expected to reach USD 9.38 billion by 2037, registering around 7.9% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of bacterial infection and technological advancement in diagnostic technology will boost the market growth.

North America industry is predicted to dominate majority revenue share of 35% by 2037, due to rising instances of fatal infections caused by bacteria in the region.

The major players in the market are bioMérieux SA, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, DiaSorin SpA (Luminex), Accelerate Diagnostics Inc., Bruker Corp., Danaher Corp., Torus Biosystems, GENERI BIOTECH s.r.o.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos